Mangoceuticals, Inc. (MGRX) Total liabilities 2022–2025
Mangoceuticals, Inc. (MGRX) total liabilities at each fiscal year-end, per SEC filings.
$890,568FY2025 · since FY2022: $389,257 → $890,568
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $890,568 | -37.5% |
| FY2024 | $1.4M | +416.4% |
| FY2023 | $276,039 | -29.1% |
| FY2022 | $389,257 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More MGRX financial trends
MGRX RevenueMGRX Net incomeMGRX Net marginMGRX Gross profitMGRX Gross marginMGRX Operating incomeMGRX Operating marginMGRX Operating cash flowMGRX Free cash flowMGRX Capital expendituresMGRX Return on equityMGRX Stock buybacksMGRX Dividends paidMGRX Total assetsMGRX Shareholders’ equityMGRX overview →